Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Acelrx Pharmaceuticals Inc (ACRX)  
$1.05 0.07 (6.25%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 8,200,000
Market Cap: 8.61(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.463 - $1.47
Level I Sector: Conglomerates
Level II Sector: Conglomerates
Level III Sector: Conglomerates

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio of products and product candidates consists of sufentanil sublingual products and product candidates, pre-filled syringe product candidates and nafamostat mesylate product candidates. Co.'s sufentanil sublingual products and product candidates include DSUVIA®, which is indicated for use in adults in supervised healthcare settings; Zalviso®, which is intended for the management of moderate-to-severe acute pain in hospitalized adult patients; and ARX-02, which is for cancer breakthrough pain in opioid-tolerant patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 10,000 20,000 66,400
Total Buy Value $0 $7,268 $15,218 $25,551
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 2 3
Total Shares Sold 0 0 16,956 16,956
Total Sell Value $0 $0 $19,235 $19,235
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 2 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 271
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mack Daniel See remarks   –       –       •   2024-03-15 4 OE $5.00 $3,775,000 I/I 755,000 1,992,519     -
   Angotti Vincent J. CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-12 4 A $1.12 $8,995 D/D 8,000 170,806     -
   Angotti Vincent J. CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-11 4 A $1.12 $1,115 D/D 1,000 162,806     -
   Palmer Pamela P Chief Medical Officer   •       –      –    2024-03-03 4 D $1.30 $585 D/D (450) 59,149     -
   Asadorian Raffi Chief Financial Officer   •       –      –    2024-03-03 4 D $1.30 $725 D/D (558) 37,733     -
   Dasu Badri N Chief Engineering Officer   •       –      –    2024-03-03 4 D $1.30 $528 D/D (406) 31,414     -
   Angotti Vincent J. Chief Executive Officer   •       •      –    2024-03-03 4 D $1.30 $2,110 D/D (1,623) 161,806     -
   Dasu Badri N Chief Engineering Officer   •       –      –    2024-02-14 4 A $0.00 $0 D/D 14,667 31,820     -
   Asadorian Raffi Chief Financial Officer   •       –      –    2024-02-14 4 A $0.00 $0 D/D 18,000 38,291     -
   Palmer Pamela P Chief Medical Officer   •       •      –    2024-02-14 4 A $0.00 $0 D/D 18,000 53,344     -
   Angotti Vincent J. Chief Executive Officer   •       •      –    2024-02-14 4 A $0.00 $0 D/D 58,667 153,429     -
   Asadorian Raffi Chief Financial Officer   •       –      –    2024-02-11 4 D $1.10 $985 D/D (895) 20,291     -
   Palmer Pamela P Chief Medical Officer   •       •      –    2024-02-11 4 D $1.10 $881 D/D (801) 35,344     -
   Dasu Badri N Chief Engineering Officer   •       –      –    2024-02-11 4 D $1.10 $890 D/D (809) 17,153     -
   Angotti Vincent J. Chief Executive Officer   •       •      –    2024-02-11 4 D $1.10 $4,095 D/D (3,723) 94,762     -
   Asadorian Raffi Chief Financial Officer   •       –      –    2024-02-10 4 D $1.10 $985 D/D (895) 21,186     -
   Palmer Pamela P Chief Medical Officer   •       •      –    2024-02-10 4 D $1.10 $881 D/D (801) 36,145     -
   Dasu Badri N Chief Engineering Officer   •       –      –    2024-02-10 4 D $1.10 $890 D/D (809) 17,962     -
   Angotti Vincent J. Chief Executive Officer   •       •      –    2024-02-10 4 D $1.10 $3,652 D/D (3,320) 98,485     -
   Jain Abhinav Director   –       •      –    2024-01-22 4 A $0.00 $0 D/D 871 871     -
   Mack Daniel 10% Owner   –       –       •   2024-01-15 3 IO $0.00 $0 I/I 0 1,237,519 33%     
   Angotti Vincent J. Chief Executive Officer   •       •      –    2023-12-13 4 B $0.73 $7,268 D/D 10,000 101,805 2.81 59%     
   Bozilenko Marina Director   –       •      –    2023-10-10 4 A $0.00 $0 D/D 581 2,606     -
   Afable Richard Director   –       •      –    2023-10-10 4 A $0.00 $0 D/D 581 2,468     -
   Wan Mark A Director   –       •      –    2023-10-10 4 A $0.00 $0 D/D 581 2,418     -
  271 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us